Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline E Ford

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Plos One|February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patientsFrancis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
British Journal of Cancer|May 13, 2021
Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agentsXing Xu, Yao Wang, Nicole S Bryce, et al.
Cancer Medicine|April 9, 2026
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma ViabilityYue Ma, Kristie-Ann Dickson, Farhana A Sarker, et al.
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
Molecular Cancer Research : MCR|September 28, 2016
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading TumorsLuke B Hesson, Benedict Ng, Peter Zarzour, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Plos One|February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patientsFrancis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
British Journal of Cancer|May 13, 2021
Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agentsXing Xu, Yao Wang, Nicole S Bryce, et al.
Cancer Medicine|April 9, 2026
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma ViabilityYue Ma, Kristie-Ann Dickson, Farhana A Sarker, et al.
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
Molecular Cancer Research : MCR|September 28, 2016
Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading TumorsLuke B Hesson, Benedict Ng, Peter Zarzour, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 5